ight therapy to prevent Oral Mucositis induced by Radiotherapy in patients with head and neck cancer

Not Applicable

• Conditions: Mucositis; C04.588.443

• Registration Number: RBR-63xd92g
• Lead Sponsor: Instituto do câncer do ceará

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-05-28
• Study Completion: 2021-12-31
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

individuals over the age of 18 of both sexes who can read and write; who have normal cognition; who have primary neoplastic lesions in the head and neck region; those who will start treatment with radio chemotherapy

Exclusion Criteria

patients previously submitted to radiotherapy and / or chemotherapy of the head and neck; patients using drugs that could interfere with oral mucositis; oral cancer patients; use of poorly adapted mobile prostheses that cause mucosal lesions; presence of limited mouth opening (less than 20 mm); cancer lesions associated with UV light; HIV patients; patients with stomatitis or other lesions of the oral cavity; decompensated diabetes; autoimmune disease or any other disease that may affect the healing mechanisms

Study & Design

• Study Type: Intervention
• Study Design: Not specified